Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Stomach Neoplasms × pertuzumab × Clear all

Phase

Status

Sponsor Class

INDUSTRY 2 OTHER 1 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 2 Stomach Neoplasms 1 Rectal Neoplasms 1 Multiple Myeloma 1 Lymphoma, Non-Hodgkin 1 Elderly Metastatic Breast Cancer Population 1 Colonic Neoplasms 1 Anatomic Stage II Breast Cancer AJCC v8 1

Interventions

Cisplatin 12 Fluorouracil 11 Leucovorin 8 Paclitaxel 7 Radiotherapy 6 Oxaliplatin 5 Capecitabine 5 Irinotecan 4 Gastrectomy 3 Epirubicin 3 Trastuzumab 2 Surgical Procedures, Operative 2 Platinum 2 Neoadjuvant Therapy 2 Docetaxel 2 uridine triacetate 1 sargramostim 1 pertuzumab 1 carfilzomib 1 Watchful Waiting 1 Taxes 1 Sorafenib 1 Ramucirumab 1 Radiosurgery 1 Preoperative Exercise 1 Polymerase Chain Reaction 1 Ondansetron 1 Lithium 1 Lapatinib 1 High-Energy Shock Waves 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02205047 2025-07-31

INNOVATION

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Completed

Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡